Drug Topics
NOVEMBER 28, 2023
Although early computed tomography (CT) screening was associated with improved cure rate for patients with lung cancer, less than 6% of the population that is eligible receives it.
Pharmacy Times
NOVEMBER 28, 2023
Tune in to this episode of the Independent Rx Forum for a comprehensive overview of the National Community Pharmacists Association's legislative priorities, updates on critical pharmacy-related bills, and insights into the legislative process.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 28, 2023
Mayo Clinic will spend $5 billion to reinvent its flagship medical campus in Rochester, Minn., infusing digital technologies into several new buildings designed to present a 21st-century vision of clinical care, the organization said Tuesday. The project, to include five new buildings with 2.4 million square feet of space, will merge Mayo’s traditional medical services with its increasing investments in artificial intelligence and digital tools.
Pharmacy Times
NOVEMBER 28, 2023
Peanut sublingual immunotherapy offers a practical treatment option for peanut-allergic toddlers, reducing symptoms in 80% of children.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
NOVEMBER 28, 2023
The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer. “Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory
Fierce Pharma
NOVEMBER 28, 2023
In a blow to CAR-T therapies, the FDA is investigating a “serious risk” of patients developing new cancers after treatment with these highly efficacious oncology drugs. | In a blow to CAR-T therapies, the FDA is investigating a “serious risk” of patients developing new cancers after treatment with these highly efficacious oncology drugs.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Pharma
NOVEMBER 28, 2023
As the pandemic eased earlier this year, officials in Poland became vocal critics of the financial obligations laid down by Pfizer’s large vaccine supply pact with the European Union. | As the pandemic eased earlier this year, officials in Poland became vocal critics of the financial obligations laid down by Pfizer’s large vaccine supply pact with the European Union.
STAT
NOVEMBER 28, 2023
WASHINGTON — President Biden is using a Cold War-era law to stem drug shortages by boosting domestic pharmaceutical manufacturing. Biden announced the initiative at the first meeting of his supply chain resilience council. It’s based on a law, the Defense Production Act, that lets the government require private companies to make materials deemed necessary for national defense, in this case essential medicines and medical countermeasures.
Pharmacy Times
NOVEMBER 28, 2023
In a phase 3 trial, none of the patients receiving nirogacestat reached median progression-free survival, indicating that it may effectively reduce disease progression.
STAT
NOVEMBER 28, 2023
Hormone replacement therapies have long been approved by the Food and Drug Administration for use by cisgender patients, such as women who take estrogen when going through menopause. Now, for the first time, a nonprofit group is pursuing research with the goal of FDA approval for the use of estrogen as a gender-affirming treatment for trans and gender-diverse patients.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
NOVEMBER 28, 2023
Gilead Sciences' Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce. | Gilead’s Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce. In a letter sent to staff this week that was obtained by Fierce Biotech, Kite Pharma Executive Vice President Cindy Perettie previewed a “refreshed business strategy” that would better align the un
STAT
NOVEMBER 28, 2023
Vertex Pharmaceuticals is being accused by a group of advocates and physicians of refusing to take several steps that would widen access to its pricey cystic fibrosis medicines in predominantly poor countries. In a recent Zoom call, company executives were urged to drop patent claims and implement a global pricing model reflecting R&D and production costs, which could make the treatments more affordable.
Pharmacy Times
NOVEMBER 28, 2023
Food insecurity was associated with an increased risk of dementia, poorer memory function, and faster memory decline in older adults.
STAT
NOVEMBER 28, 2023
In response to strained budgets, a growing number of state and local governments across the U.S. are suing insulin makers and pharmacy benefit managers over claims the companies conspired to illegally drive up prices. In recent weeks, state officials in Utah and Arizona , and municipalities in New York, Virginia , Maryland, and Ohio have filed lawsuits alleging that the companies artificially drove up the cost of insulin, making the medication unaffordable for countless residents who have diabet
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
NOVEMBER 28, 2023
Healthcare continues to be a hiring hotspot and LinkedIn aims to stay competitive as new staffing startups jump into the market. | Healthcare continues to be a hiring hotspot and LinkedIn aims to stay competitive as new staffing startups jump into the market.
STAT
NOVEMBER 28, 2023
Investors , analysts, doctors, and even patients face an avalanche of news from biotech companies about their human trials of experimental drugs, and wading through all that data to draw reasonable conclusions is a challenging task. This week, STAT has published a 2023 update of its Guide to Interpreting Clinical Trial Results, which can help consumers of company readouts navigate the process.
Pharmacy Times
NOVEMBER 28, 2023
The finding indicates that a potential vaccine can trigger a permanent response in individuals living with HIV-1.
Fierce Healthcare
NOVEMBER 28, 2023
The Patient-Centered Outcomes Research Institute (PCORI) has announced funding awards of $80.5 million to support four new studies focused on disparities in maternal health. | The studies will compare a range of practice-level and community- and home-based interventions to address common challenges in maternal health.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
NOVEMBER 28, 2023
Novartis is getting more optimistic about its midterm sales potential, thanks to bullish estimates for some blockbuster drugs. | Novartis is getting more optimistic about its midterm sales potential, thanks to bullish estimates for some blockbuster drugs, including Entresto and Kisqali.
Fierce Healthcare
NOVEMBER 28, 2023
Chronic kidney disease is a significant public health issue. Nationwide, roughly 37 million Americans live with chronic kidney disease. | This week on "Podnosis," Senior Editor Heather Landi sits down with Misha Palecek, who leads DaVita’s strategic value-based care partnerships and care delivery innovations, to discuss why the shift to value-based care is critical in raising the bar on kidney care and addressing widespread healthcare disparities.
Fierce Pharma
NOVEMBER 28, 2023
Armed with a full FDA approval after four years supplying its anthrax vaccine under a pre-emergency use authorization, Emergent BioSolutions is expanding its countermeasure supply pact with the Uni | Armed with a full FDA approval after four years supplying its anthrax vaccine under a pre-emergency use authorization, Emergent BioSolutions is expanding its countermeasure supply pact with the United States.
Pharmacy Times
NOVEMBER 28, 2023
Regardless of which of these vaccines patients receive, as long as they receive them according to the prescribed schedules, they can protect themselves and their community against the COVID-19 virus.
The Checkup by Singlecare
NOVEMBER 28, 2023
You sit cross-legged for too long, and that familiar feeling of pins and needles starts to creep in after your foot falls asleep. But what about a total loss of feeling, like numbness in the toes? Numb toes can happen for a variety of reasons. Sometimes, numbness in your toes is a temporary issue caused by ill-fitting shoes or spending too long out in the cold.
Fierce Healthcare
NOVEMBER 28, 2023
Employers are going to be expecting more from their partners going into 2024 as they look to address issues ranging from mental health to drug costs to wellness. | Employers are going to be expecting more from their partners going into 2024 as they look to address issues ranging from mental health to drug costs to wellness.
pharmaphorum
NOVEMBER 28, 2023
Putting patients at the centre of innovation starts with clinical trial access Mike.
STAT
NOVEMBER 28, 2023
WASHINGTON — A top White House official on Tuesday delivered a pointed attack at a drugmaker fighting the administration’s Medicare negotiation plan in court. Christen Linke Young, White House Domestic Policy Council’s deputy assistant to the president for health and veterans affairs, took on Bristol-Myers Squibb, which makes the blockbuster blood thinner Eliquis.
pharmaphorum
NOVEMBER 28, 2023
Veeva Commercial Summit '23: The power of connectivity Mike.
STAT
NOVEMBER 28, 2023
Belgium drugmaker Argenx said Tuesday that its antibody medicine failed to achieve the goals of a late-stage study for a platelet-destroying autoimmune disorder — a setback in the company’s efforts to expand the drug’s use. Argenx shares were down 12% in early trading. The negative study, called ADVANCE-SC, was the second of two clinical trials involving the Argenx drug called efgartigimod in patients with primary immune thrombocytopenia (ITP), a debilitating condition that
pharmaphorum
NOVEMBER 28, 2023
Reducing the stigma attached to psychedelics Mike.
Drug Topics
NOVEMBER 28, 2023
Maintaining the structure and function of antibody biologics like faricimab is critical for their administration via intravitreal injection (IVI), a common treatment approach for retinal diseases.
pharmaphorum
NOVEMBER 28, 2023
IPF: Could we reverse the progression? Mike.
Fierce Pharma
NOVEMBER 28, 2023
Dermavant CEO Todd Zavodnick isn’t concerned with the slow uptake of the hyped plaque psoriasis drug Vtama. He points to another breakthrough treatment which took a while to catch on: Botox. | Dermavant CEO Todd Zavodnick isn’t concerned with the slow uptake of hyped plaque psoriasis drug Vtama. He points to another breakthrough treatment which took a while to catch on—Botox.
pharmaphorum
NOVEMBER 28, 2023
How clinical research is zeroing in on fatty liver disease Mike.
Expert insights. Personalized for you.
200 
Let's personalize your content